Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

Artemis DNA, Inc. (“Artemis DNA” or the “company”), a leading global diagnostic laboratory company, announced today that they have made the difficult decision to close their Houston, Texas facility. “This was certainly

Share
Artemis DNA Forays Into Multi-Billion Dollar Cancer Liquid Biopsy Market

The $250 million contract gives Artemis DNA exclusivity to commercialize and distribute Trucheck Pragma and Cancertrack liquid biopsy tests in the USA and Vietnam. Artemis DNA, Inc. (“Artemis DNA” or the

Share
Artemis DNA Wins 2022 Association for Corporate Growth Award

Artemis DNA, Inc. (“Artemis DNA” or the “company”), the US-based leading genetics company, proudly announced today that they have been selected as the winner of the Association of Corporate Growth (ACG)

Share
Artemis DNA, Genetic and Diagnostic Testing Company, Expands Services Internationally to Vietnam

Artemis DNA will begin offering groundbreaking cutting-edge genetic testing and early cancer detection technology to the people of Vietnam. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity

Share
Artemis DNA Clinical Medical Laboratory Receives Second Accreditation From the College of American Pathologists

Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical

Share
Artemis DNA, Genetic Testing Company, Reserves 100 VinFast EV as part of ESG Initiatives

Furthering its strong commitment to ESG initiatives, clinical diagnostic laboratory company becomes first U.S. corporate customer for EV-maker VinFast with reservation for 100 vehicles. Irvine, Calif., January 8, 2022 — Artemis

Share
Artemis DNA Announced as Winner of OC Register’s 2021 Top Workplaces

Irvine, Calif., November 30, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic

Share
Artemis DNA Promoted General Counsel, Margaret Kivinski, to Chief Legal Officer and Corporate Secretary

Irvine, Calif., November 30, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic

Share
Artemis DNA General Counsel, Margaret Kivinski, Nominated for OCBJ General Counsel Awards

Irvine, Calif., November 4, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and

Share
Artemis DNA Announced Ann Sabahat as Chief Financial Officer

Irvine, Calif., October 12, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic

Share
Artemis DNA Founder and CEO, Emylee Thai, Nominated for OCBJ Women in Business Awards

Irvine, Calif., August 9, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and

Share